|
|
| Line 1: |
Line 1: |
| {{DrugProjectFormSinglePage
| |
| |authorTag={{PB}}
| |
| |genericName=Trimipramine
| |
| |aOrAn=a
| |
| |drugClass=Tricyclic antidepressant
| |
| |indication=depression
| |
| |hasBlackBoxWarning=Yes
| |
| |adverseReactions=hypotension, tachycardia, constipation, xerostomia, dizziness, somnolence, blurred vision
| |
| |blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
| |
| |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
| |
| |fdaLIADAdult=<h4>Depression</h4>
| |
|
| |
|
| * 75 mg PO (divided into 1-3 doses per day), increase gradually to 150 mg/day to maximum 200 mg/day for outpatient treatment. Maintenance 50-150 mg/day PO, bedtime, for 3 months.
| |
| *100 mg PO (divided into 1-3 doses per day), increase gradually to 200 mg/day, if unsatisfactory response in in 2-3 weeks, increase to a maximum 300 mg/day for inpatient treatment.
| |
| |offLabelAdultGuideSupport=<b>Condition 1</b>
| |
|
| |
| * Developed by: (Organization)
| |
|
| |
| * Class of Recommendation: (Class) (Link)
| |
|
| |
| * Strength of Evidence: (Category A/B/C) (Link)
| |
|
| |
| * Dosing Information/Recommendation
| |
|
| |
| :* (Dosage)
| |
| |offLabelAdultNoGuideSupport=:* There is limited information about <i>Off-Label Non–Guideline-Supported Use</i> of Trimipramine in adult patients.
| |
| |fdaLIADPed=<h4>Depression</h4>
| |
|
| |
| *FDA approved for adolescents, and not for children.
| |
| * 50 mg/day PO may increase up to 100 mg/day for adolescents;
| |
| |offLabelPedGuideSupport=<b>Condition 1</b>
| |
|
| |
| * Developed by: (Organization)
| |
|
| |
| * Class of Recommendation: (Class) (Link)
| |
|
| |
| * Strength of Evidence: (Category A/B/C) (Link)
| |
|
| |
| * Dosing Information/Recommendation
| |
|
| |
| :* (Dosage)
| |
| |offLabelPedNoGuideSupport=:* There is limited information about <i>Off-Label Non–Guideline-Supported Use</i> of Trimipramine in pediatric patients.
| |
| |contraindications=* Condition 1
| |
| * Condition 2
| |
| * Condition 3
| |
| * Condition 4
| |
| * Condition 5
| |
| |warnings=<b>Conidition 1</b>
| |
|
| |
| (Description)
| |
| |clinicalTrials=<b>Central Nervous System</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Cardiovascular</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Respiratory</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Gastrointestinal</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Hypersensitive Reactions</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Miscellaneous</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
| |postmarketing=<b>Central Nervous System</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Cardiovascular</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Respiratory</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Gastrointestinal</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Hypersensitive Reactions</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
|
| |
| <b>Miscellaneous</b>
| |
|
| |
| : (list/description of adverse reactions)
| |
| |drugInteractions=* (Drug 1)
| |
| :* (Description)
| |
|
| |
| * (Drug 2)
| |
| :* (Description)
| |
|
| |
| * (Drug 3)
| |
| :* (Description)
| |
| |fdaPatientInfo=For patient information about Trimipramine from NLM, click [[Trimipramine (patient information)
| |
| |alcohol=Alcohol-Trimipramine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
| |
| }}
| |